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Abstract
Introduction:  Thoracoscopy  is  increasingly  being  used  in  the  treatment  of  empyema.  This  study
assesses feasibility,  efﬁcacy  and  safety  in  children.
Material  and  methods:  Clinical  ﬁles  of  patients  who  underwent  primary  thoracoscopy  for
empyema  between  2006  and  2014  were  reviewed.  Demographic,  clinical  and  surgical  data  were
analyzed and  a  comparison  between  the  period  before  (period1)  and  after  (period2)  the  learning
curve was  performed.
Results:  Ninety-one  patients  (53  males,  58%)  were  submitted  to  thoracoscopy  at  a  median  age
of 4  years.  There  were  19  conversions  to  thoracotomy  with  a  steady  decrease  of  conversion
rate until  2009  (period1)  and  no  conversions  thereafter  (period2).  There  was  no  difference  in
any of  the  analyzed  parameters  between  patients  submitted  to  thoracoscopy  alone  and  those
requiring conversion  in  period1.  Six  cases  (6.6%)  needed  redo-operation  (ﬁve  in  period2)  and
thoracotomy  was  the  elected  approach  in  four.  Necrotizing  pneumonia  was  present  in  60%  of
the reoperated  cases;  in  other  words,  in  period2  3  out  of  9  cases  with  necrotizing  pneumonia
required reintervention  (p  =  0.07).  Thoracotomy  was  avoided  in  sixty-eight  (75%)  patients  (62%
in period1  versus  92%  in  period2,  p  =  0.001).
Discussion  and  conclusions:  Thoracoscopic  approach  for  empyema  is  feasible  and  safe  avoiding
a signiﬁcant  number  of  thoracotomies  after  a  short  learning  curve.  An  increase  of  reintervention This study results from the collaboration of two departments; therefore the limit of six authors was exceeded.
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rate  should  be  expected,  but  throracoscopy  alone  is  effective  in  the  great  majority  of  the
cases. Necrotizing  pneumonia  may  be  associated  with  a  higher  risk  of  reintervention,  as  it  is  a
contra-indication  to  thoracoscopy  and  probably  surgery.
© 2015  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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ontroduction
he  incidence  of  empyema  in  children  is  increasing
orldwide.1,2 Empyema  occurs  in  nearly  1  in  150  chil-
ren  hospitalized  with  pneumonia,  affecting  about  3.3
er  100  000  children.3,4 In  contrast  to  their  adult  coun-
erparts,  children  with  empyema  usually  have  a normal
nderlying  lung  and  suppuration  within  the  pleural  cav-
ty  is  most  commonly  a  complication  of  acute  bacterial
neumonia.  Prognosis  is  excellent  when  appropriate  treat-
ent  is  administered  early.  Therapeutic  options  in  children
nclude  systemic  antibiotics,  thoracocentesis,  chest  drain,
brinolytic  agents,  and  several  surgical  techniques  such  as
horacoscopy,  video-assisted  thoracoscopic  surgery  (VATS),
ini-thoracotomy,  and  standard  thoracotomy  with  lung
ecortication.  No  consensus  has  been  reached  about  the
ptimal  therapeutic  strategy  for  pediatric  empyema.  A
ystematic  review  of  randomized  controlled  trials  (RCT)
ncluded  three  small  RCTs  comparing  the  outcomes  of  ﬁb-
inolytics  and  VATS  with  discordant  ﬁndings:  one  study
uggested  better  outcomes  with  primary  operative  treat-
ent,  but  the  other  two  found  no  signiﬁcant  difference
n  the  measured  outcomes  except  for  the  lowest  cost  of
brinolytics.3,5 The  most  recent  randomized  multicenter
linical  trial,  concluded  that  drainage  plus  urokinase  instilla-
ion  is  as  effective  as  VATS  as  ﬁrst-line  treatment  of  septated
mpyema  in  children.6
Despite  the  enthusiasm  around  minimally  invasive  sur-
ical  approaches,  conversion  and  reintervention  during  the
horacoscopic  management  of  pediatric  empyemas  have  not
een  profoundly  studied  as  in  adults  literature.7
The  aim  of  this  work  is  to  assess  the  feasibility,  efﬁcacy
nd  safety  of  thoracoscopic  approach  in  a  series  of  pediatric
mpyema.
aterials and methods
tudy  design  and  patient  selection
ll  pediatric  patients  (aged  <18  years)  admitted  between
anuary  2006  and  December  2014  at  Hospital  São  João  in
orto,  Portugal  with  empyema  associated  with  community-
cquired  pneumonia  were  eligible.  An  empyema  was  deﬁned
s  a  loculated  or  septated  effusion  by  imagiologic  study
r  ﬁnding  of  pus  or  loculated  effusion  at  the  time  of  sur-
ical  intervention.  Necrotizing  pneumonia  was  deﬁned  as
ultiple  small  lucencies  or  cavities  of  non-enhancement
n  a  contrast-enhanced  chest  computed  tomography  (CT).
S
S
satients  submitted  to  non-operative  treatment  or  primary
horacotomy  were  excluded;  only  patients  who  underwent
rimary  thoracoscopic  management  were  included  in  this
tudy.
The  following  data  were  retrieved  from  the  patient
ecords:  demography  (age,  sex,  date  of  empyema  diagno-
is),  clinical  presentation  (duration  of  preoperative  fever,
uration  of  preoperative  empyema,  pneumonia  character-
stics  --  such  as  necrotizing  pneumonia,  empyema  location,
ntensive  care  unit  (ICU)  admission),  preoperative  investi-
ations  (analytical  inﬂammatory  markers,  chest  radiograph,
hest  ultrasound  and  chest  computed  tomography,  the  use  of
reoperative  chest  tube),  antibiotic  usage,  operative  details
duration  of  surgery,  number  of  trocars  used,  intraoperative
omplications,  conversion  to  open  procedure)  and  outcomes
complications  including  hemorrhage,  pneumatocele,  bron-
hopleural  ﬁstula  and  postoperative  need  for  mechanical
entilation,  duration  of  postoperative  fever,  duration  of
ostoperative  chest  tube,  duration  of  hospital  stay  and  mor-
ality).  Surgical  delay  was  deﬁned  as  the  number  of  days
rom  the  diagnosis  to  thoracoscopic  treatment.
The  learning  curve  was  deﬁned  as  the  period  when
onversion  occurred  (period1),  the  period  thereafter  was
eﬁned  as  period2.
Patients  submitted  to  thoracoscopy  alone  were  compared
ith  those  requiring  conversion  (during  period1)  regarding
reoperative  data,  operative  details  and  outcomes.  Patients
eeding  reoperation  during  period2  were  analyzed  in  a
earch  for  possible  predictors  of  reintervention.
Globally,  patients  with  necrotizing  pneumonia  were  com-
ared  with  those  without  this  diagnosis  regarding  the
reoperative  data,  operative  details  and  outcomes.
urgical  techniques
atients  were  submitted  to  thoracoscopy  using  either  two
r  three  trocars;  in  case  of  conversion  or  reoperation  the
osterolateral  thoracotomy  approach  was  used.  At  the  com-
letion  of  the  procedure  one  or  two  chest  tubes  were
nserted  under  thoracoscopic  visualization  and  removed
hen  drainage  was  minimal.  Patients  were  discharged  after
hest  tube  removal  and  completion  of  intravenous  antibi-
tics.tatistical  methods
tatistical  analysis  was  conducted  using  SPSS® software,  ver-
ion  22  and  all  reported  p  values  are  two-tailed,  statistical
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Empyema
Thoracoscopy
No conversion
No reintervention
Thoracoscopic
reintervention
Thoracotomy
reintervention
No
reintervention
Conversion
N=187
N=91
N=72
N=66 N=2 N=4 N=19
N=19
emographic  data.
Table  1  Clinical  and  surgical  data.
Variable Mean  ±  SD  or  N  (%)
Age  (years)  5.2  ±  3.7
Male 53  (58)
Duration  of  preoperative  fever  (days)  8.6  ±  3.5
Surgical  delay  (days)  3.0  ±  3.0
Necrotizing  pneumonia  15  (16)
Preoperative  chest  tube  drainage  16  (18)
Preoperative  ICU  admission  5  (5)
CRP level  (mg/L) 195.9  ±  107.4
Empyema  location
Left  38  (42)
Right  49  (54)
Bilateral  4  (4)
Preoperative  imaging  evaluation
Chest  X  ray  91  (100)
Chest  ultrasonography  89  (98)
Chest  computed  tomography  32  (35)
Duration  of  surgery  (min)  106  (30--254)
Number  of  trocars
2  62  (68)
3 19  (21)
Postoperative  fever  (days)  3.5  ±  5.1
Postoperative  drainage  (days)  5.6  ±  4.1
Postoperative  stay  (days) 11.1  ±  7.9
Early  complications  9  (9.9)Figure  1  D
signiﬁcance  set  at  5%.  Frequencies  were  compared  with
Fisher’s  exact  test  for  categoric  variables,  and  continuous
variables  were  compared  using  the  t  test  and  analysis  of
variance.
Results
From  January  2006  to  December  2014,  91  out  of  187
pediatric  patients  with  empyema  in  our  institution  were  sub-
mitted  to  thoracoscopic  management  (Fig.  1).  There  were
53  boys  (58.2%)  and  38  girls  (41.8%)  with  an  age  of  5.2  ±  3.6
years.  Fifty  patients  (55%)  were  referred  from  other  hospi-
tals.  Clinical,  radiologic  and  surgical  data  are  presented  in
Table  1.
Period1  extended  until  2009  and  there  were  19  (56%)
conversions  to  thoracotomy  with  a  steady  decrease  in
the  conversion  rate;  in  the  period2  from  2010  to  2014
there  were  no  conversions.  The  comparison  between  con-
verted  and  non-converted  cases  during  period1  is  presented
in  Table  2.  The  most  frequent  cause  of  conversion  was
organized  empyema  with  thick  ﬁbrin  peel  in  14  patients,
followed  by  necrotizing  pneumonia  with  ﬁstula  (3),  bleeding
(1)  and  diaphragmatic  perforation  (1).
Overall  reintervention  rate  was  6.6%  (6  cases)  and  tho-
racothomy  was  the  elected  approach  for  reoperation  in
four  cases.  None  of  the  converted  cases  was  reoperated.
There  was  a  higher  reintervention  rate  in  period2  than  in
period1  (1/52,  1.9%  vs.  5/39,  12.8%,  p  =  0.08).  Fistula  was
the  most  common  cause  of  reintervention  and  was  associ-
ated  with  pneumonia  (3  cases)  or  pneumatocele  (1  case);
relapse  was  the  cause  of  reoperation  in  the  remaining  two
cases.  Necrotizing  pneumonia  was  present  in  60%  of  the
reoperated  cases,  in  other  word,  in  period2  3  out  of  9
cases  with  necrotizing  pneumonia  required  reintervention
(p  =  0.07).
f
w
pLate complications 2  (2.2)
Mortality  0Thoracoscopic  approach  spared  68  patients  (75%)
rom  thoracotomy;  a  higher  proportion  of  patients
ere  spared  after  2009  (62%  period1  vs.  92%  period2,
 <  0.001).
160  R.  Lamas-Pinheiro  et  al.
Table  2  Comparative  data  of  converted  and  non-converted  patients  (period1)  and  intervened  and  non-intervened  patients
(period2).
Variable  Median  (range)  or  N  (%)  p  value  Median  (range)  or  N  (%)  p  value
No  conversion
(33)
Conversion  (19)  No  reintervention
(34)
Reintervention
(5)
Male  21  (63.6) 10  (52.6) 0.436 20  (58.8) 2  (40.0)  0.636
Age (years) 5.0  (1--16) 4.0  (1--7) 0.192 4.0  (0--17) 5.0  (2--11) 0.766
Preoperative  fever  (days)  8.0  (3--25)  9.0  (3--17)  0.770  8.0  (3--16)  9.0  (7--13)  0.446
Surgical delay  (days)  2.0  (0--13)  2.5  (0--11)  0.296  2.0  (0--9)  1.0  (0--8)  0.897
CRP level  (mg/L)  206.8
(25.7--497.9)
181.9
(60.6--397.4)
0.790  214.6  (13.9--924.0)  227.5
(81.4--342.0)
0.599
Necrotizing  pneumonia  2  (6.1)  4  (21.0)  0.175  6  (17.6)  3  (60.0)  0.070
Preoperative  drainage  5  (15.2)  4  (21.0)  0.708  6  (17.6)  1  (20.0)  1.0
Empyema location  (R|L|B)  18  (55)|12
(36)|3 (9)
9  (47)|9  (47)|1
(5)
0.856  20  (58)|14  (41)|0
(0)
2  (40)|3  (60)|0
(0)
0.636
Postoperative  drainage
(days)
5.0  (2--15)  5.0  (2--16)  0.278  4.0  (1--16)  3.0  (2--26)  0.913
Early complications  2  (6.1)  3  (15.8)  0.342  2  (5.9)  2  (40.0)  0.072
Late complications 0  (0)  1  (5.3)  0.365  0  (0)  1  (20.0)  0.128
a
t
l
p
D
T
c
l
i
t
s
t
f
m
e
t
a
f
t
i
t
q
o
i
i
a
t
v
c
r
f
c
t
m
i
d
o
d
p
8
i
i
a
t
i
s
a
t
i
c
s
w
h
p
f
p
d
s
a
o
t
l(R|L|B) -- (Right | Left | Bilateral).
There  were  no  recurrences  after  hospital  discharge,  with
 follow-up  ranging  from  1  to  27  months  (median,  6  months).
Globally,  patients  with  necrotizing  pneumonia  were  iden-
ical  regarding  all  clinical  data,  except  for  longer  overall
ength  of  stay  (median  20  versus  12,  p  =  0.004)  and  longer
ost-operative  length  of  stay  (17  versus  8,  p  =  0.002).
iscussion
he  optimal  management  of  pediatric  empyema  remains
ontroversial.8 Thoracocentesis  and  antibiotics  alone  have
ow  success  rate  (6--20%)  in  the  treatment  of  empyema,  even
n  early  stage  disease.  The  role  of  thoracoscopy  as  compared
o  ﬁbrinolysis  in  pediatric  empyema  is  still  controversial:
tudies  comparing  the  effectiveness  of  ﬁbrinolytics  versus
horacoscopy  suggest  a  higher  rate  of  primary  treatment
ailure  in  the  ﬁbrinolytics  approach;9--11 however,  a  recent
ulticenter  RCT  concluded  that  ﬁbrinolytics  instillation  is  as
ffective  as  video-assisted  thoracoscopic  surgery  for  primary
reatment  of  pediatric  septated  empyema.6 Our  institution
pproach  has  been  in  favor  of  early  surgical  intervention
ollowing  the  IPEG  guidelines;12 as  the  placement  of  a  chest
ube  in  such  young  patients  requires  anesthesia,  this  timing
s  used  for  a  diagnostic  thoracoscopy  and  proceeding  with
he  treatment.12
Conversion  rates  from  thoracoscopy  to  thoracotomy  are
uite  different  among  studies,  ranging  from  5.6%  to  61%.7 In
ur  study,  the  overall  conversion  rate  was  21%,  however  it
s  worth  noting  that  after  the  introduction  of  thoracoscopy
n  our  institution,  thoracoscopy  was  always  the  ﬁrst-line
pproach  independently  of  the  stage  of  the  empyema  and
hat  might  have  resulted  in  higher  conversion  and  reinter-
ention  rates.
Additionally,  there  was  a  signiﬁcant  reduction  of  the
onversion  rate  in  the  ﬁrst  four  years  (period1).  As  patients
equiring  conversion  during  this  period  were  no  different
p
i
r
4rom  those  submitted  to  thoracoscopy  alone,  this  reduction
ould  be  fully  explained  by  a  learning  curve  associated  with
he  increased  surgical  expertise.  There  was  no  increased
orbidity  or  mortality  associated  with  conversion,  mean-
ng  that  the  thoracoscopic  learning  curve  is  safe  with  no
etriment  for  the  patients.  Our  results  concur  with  previ-
us  series  reporting  postoperative  fever  lasting  2--5  days,
uration  of  postoperative  chest  tube  of  4--6  days,  median
ostoperative  stay  of  6--13  days  and  total  hospital  stay  of
--21  days. 9,13 Therefore,  pediatric  surgeons  with  expertise
n  open  approach  should  be  encouraged  to  progressively  step
nto  minimally  invasive  surgical  techniques  embracing  their
dvantages  without  fearing  an  increased  morbidity.  After
he  learning  curve,  there  was  no  conversion  but  an  increase
n  reintervention  rate  was  identiﬁed;  nevertheless  thoraco-
copic  approach  means  the  great  majority  (92%)  of  patients
re  spared  thoracotomy.  The  parallel  increase  in  the  rein-
ervention  rate  along  with  decrease  in  conversion  rate  may
ndicate  that  a  subset  of  patients  ultimately  needs  a  thora-
otomy;  however,  our  sample  was  too  small  to  conﬁrm  this
tatement.
Early  surgical  intervention  has  already  been  associated
ith  better  outcomes  such  as  simpler  procedures,  shorter
ospitalization,  shorter  intravenous  antibiotic  therapy,  less
ostoperative  complications  and  more  important  lower
ailure  of  the  thoracoscopic  approach  in  both  adult  and
ediatric  patients.4,7,12,14--18 In  our  series,  preoperative  fever
uration  was  not  related  either  to  reintervention  or  conver-
ion  rates.  The  fever  was  the  only  studied  symptom  and  on
verage  our  patients  were  operated  eight  days  after  the
nset  of  this  symptom,  with  a  short  surgical  delay:  in  median
horacoscopy  was  performed  two  days  after  diagnosis.  In  the
iterature,  a  great  importance  is  given  to  early  transfer  and
rompt  surgery  to  achieve  more  favorable  outcomes,  reduc-
ng  the  morbidity  and  mortality.17--20 Previous  studies  have
ecommended  the  surgical  intervention  not  delayed  beyond
--7  days.18,19
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Apart  from  the  comparison  studies  between  early  and
delayed  interventions,  one  study  analyzed  CT  scan  features
from  adult  empyema  (amount  of  pleural  ﬂuid,  type  of  effu-
sion,  number  of  loculations,  pleural  ﬂuid  characteristics  and
pleural  thickening)  and  concluded  that  patients  presenting
with  fever  and  pleural  thickening  and  who  are  operated  on
more  than  20  days  after  the  onset  of  symptoms  are  likely  to
require  a  thoracotomy  for  appropriate  treatment.7 CT  scan
data  could  be  important  in  predicting  either  conversion  or
reintervension,  unfortunately  we  are  unable  to  obtain  CT
scan  data  from  all  patients,  as  this  exam  is  not  routinely
performed  in  the  pediatric  population  because  of  its  associ-
ated  radiation.  Nevertheless,  our  data  suggest  a  relationship
between  necrotizing  pneumonia  on  CT  scan  and  reinterven-
tion.  Moreover  necrotizing  pneumonia  was  associated  with
increased  length  of  hospital  stay.
The  radiation  exposure  imposes  a  challenge  in  the  diagno-
sis  of  necrotizing  pneumonia  in  the  pediatric  population.  In
result,  pulmonary  necrosis  is  probably  under-diagnosed  dur-
ing  the  preoperative  evaluation  of  empyema;  it  is  of  utmost
importance  to  establish  the  difference  between  empyema
and  pulmonary  necrosis,  as  this  interferes  in  the  treatment
and  outcome.21,22 The  risk  and  beneﬁts  of  the  CT  scan  should
be  evaluated  or  in  alternative,  a  magnetic  resonance  imag-
ing  (MRI)  can  be  performed.
Conclusions and limitations
In  conclusion,  thoracoscopic  approach  for  empyema  is  feasi-
ble  and  safe  avoiding  a  signiﬁcant  number  of  thoracotomies
after  a  rapid  learning  curve.  An  increase  in  the  reinterven-
tion  rate  should  be  expected  thereafter,  but  thoracoscopy
alone  is  effective  in  the  great  majority  of  the  cases.
Necrotizing  pneumonia  in  the  CT  scan  is  possibly  associ-
ated  with  reintervention.  Beside  the  retrospective  nature  of
the  study,  the  major  limitation  was  the  mentioned  lack  of
descriptors  of  empyema,  as  ultrasound  descriptions  are  not
standardized  and  CT  scan  is  only  ordered  in  few  pediatric
patients.  In  the  future,  preoperative  ultrasound  or  MRI  fea-
tures  should  also  be  considered  in  a  larger  prospective  study
in  order  to  determine  predictors  of  failure  of  thoracoscopic
approach.
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